# Armata Pharmaceuticals, Inc.: Form 4, filed Feb 11, 2022

- Company: [Armata Pharmaceuticals, Inc.](/companies/armp.md) (CIK 921114)
- Form: 4
- Filed: 2022-02-11
- Accepted by EDGAR: Feb 11, 2022, 18:56 ET
- Period: 2022-02-09
- Accession: 0001567619-22-003750
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/921114/000156761922003750/xslF345X03/doc1.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/921114/000156761922003750/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/921114/000156761922003750/xslF345X03/doc1.xml

Filed Feb 11, 2022.
Source: SEC EDGAR, the filing index for accession 0001567619-22-003750. Last ingested by Listed: Oct 24, 2026, 15:00 ET. No prices; not investment advice.
